Abeona Therapeutics Wins FDA Approval For First-of-Its-Kind Gene Therapy

benzinga.com/general/biotech/25/04/45080457/abeona-therapeutics-wins-fda-approval-for-first-of-its-kind-gene-therapy

The U.S. Food and Drug Administration (FDA) on Tuesday approved Abeona Therapeutics Inc.’s (NASDAQ:ABEO) Zevaskyn (prademagene zamikeracel) gene-modified cellular sheets, also known as pz-cel, as the first and only autologous cell-based gene therapy for wounds in adult and pediatric…

This story appeared on benzinga.com, 2025-04-29 19:06:43.
The Entire Business World on a Single Page. Free to Use →